AU2001294141A1 - Crystalline fgf9 dimer and methods of use - Google Patents

Crystalline fgf9 dimer and methods of use

Info

Publication number
AU2001294141A1
AU2001294141A1 AU2001294141A AU9414101A AU2001294141A1 AU 2001294141 A1 AU2001294141 A1 AU 2001294141A1 AU 2001294141 A AU2001294141 A AU 2001294141A AU 9414101 A AU9414101 A AU 9414101A AU 2001294141 A1 AU2001294141 A1 AU 2001294141A1
Authority
AU
Australia
Prior art keywords
fgf9
dimer
crystalline
methods
fgf9 dimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294141A
Inventor
Rivka Adar
Oren Bogin
Hans-Juergen Hecht
Herbert Weich
Avner Yayon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Prochon Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prochon Biotech Ltd filed Critical Prochon Biotech Ltd
Publication of AU2001294141A1 publication Critical patent/AU2001294141A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AU2001294141A 2000-09-19 2001-09-16 Crystalline fgf9 dimer and methods of use Abandoned AU2001294141A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23366500P 2000-09-19 2000-09-19
US60/233,665 2000-09-19
PCT/IL2001/000871 WO2002024722A2 (en) 2000-09-19 2001-09-16 Crystalline fgf9 dimer and methods of use

Publications (1)

Publication Number Publication Date
AU2001294141A1 true AU2001294141A1 (en) 2002-04-02

Family

ID=22878187

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294141A Abandoned AU2001294141A1 (en) 2000-09-19 2001-09-16 Crystalline fgf9 dimer and methods of use

Country Status (2)

Country Link
AU (1) AU2001294141A1 (en)
WO (1) WO2002024722A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU697465B2 (en) * 1994-11-02 1998-10-08 Research Foundation Of The State University Of New York, The Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
US6020189A (en) * 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use

Also Published As

Publication number Publication date
WO2002024722A3 (en) 2002-09-12
WO2002024722A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2001229712A1 (en) Reduction of hair growth
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001266124A1 (en) 2-aminothiazoline derivatives and their use as no-synthase inhibitors
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001268236A1 (en) Use of aicar and related compounds
AU4432001A (en) Trityl-type compounds and their use
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2001245950A1 (en) Preparation of deoxynucleosides
AU2001294141A1 (en) Crystalline fgf9 dimer and methods of use
AU2001272490A1 (en) Use of galiella lactone
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2002355432A1 (en) Kavalactone compositions and methods of use